- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Antiviral Therapy for Chronic Hepatitis B in Pregnancy ; volume:33 ; number:02 ; year:2013 ; pages:138-146
Seminars in liver disease ; 33, Heft 02 (2013), 138-146
- Contributor
-
Pan, Calvin Q.
Lee, Hannah M.
- DOI
-
10.1055/s-0033-1345718
- URN
-
urn:nbn:de:101:1-2019040513420835568479
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pan, Calvin Q.
- Lee, Hannah M.
Other Objects (12)
Antiviral-Resistant Fulminant Herpes Hepatitis in Pregnancy
Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Targets for Antiviral Therapy of Hepatitis C
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
Hepatitis C virus: from molecular virology to antiviral therapy
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
Antiviral therapy in acute viral hepatitis B: why and when
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis
Antiviral-Resistant Fulminant Herpes Hepatitis in Pregnancy
Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Targets for Antiviral Therapy of Hepatitis C
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
Hepatitis C virus: from molecular virology to antiviral therapy
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
Antiviral therapy in acute viral hepatitis B: why and when
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis
Antiviral-Resistant Fulminant Herpes Hepatitis in Pregnancy
Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Targets for Antiviral Therapy of Hepatitis C
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
Hepatitis C virus: from molecular virology to antiviral therapy
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
Antiviral therapy in acute viral hepatitis B: why and when
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use